Skip to main content
SpringerLink
Log in

Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

There is no known biological requirement for germanium (Ge), germanates, or any organogermanium compound. Ge deficiency has not been demonstrated in any animal. The estimated average dietary intake of Ge in humans is 1.5 mg/d. Ge is widely distributed in edible foods, all of which, with few exceptions, contain less than 5 ppm Ge, since higher levels are toxic to most plants. Ingestion of Ge compounds has been shown to produce toxic effects in experimental animals.

In recent years inorganic germanium salts and novel organogermanium compounds, such as carboxyethyl germanium sesquioxide (Ge-132) and lactate-citrate-germanate (Ge lactate citrate) have been sold as “nutritional supplements” in some countries for their purported immunomodulatory effects or as health-producing elixirs, resulting sulting in intakes of Ge significantly exceeding the estimated average dietary intake. Since 1982, there have been 18 reported cases of acute renal dysfunction or failure, including two deaths, linked to oral intake of Ge elixirs containing germanium dioxide (GeO2) or Ge-132. In these cases, biopsies show vacuolar degeneration in renal tubular epithelial cells, without proteinuria or hematuria, in the absence of glomerular changes. Serum creatinine levels have been well above 400 μmol/L in such patients. In 17 of 18 cases, accumulated elemental Ge intakes reportedly ranged between 16 to 328 g over a 4–36 mo period, or between 100 to 2000 times the average estimated dietary intake for human. In surviving patients, renal function improved after discontinuation of Ge supplementation. However, in no case was recovery complete.

One organogermanium compound, an azaspiran organogermanium compound, 2-aza-8-germanspiro[4,5] decane-2-propamine-8,8-diethyl-N,N-dimethyl dichloride (spirogermanium), has been found to cause both neurotoxicity and pulmonary toxicity in phase I and II studies examining its chemotherapeutic potential as an antitumor drug in the treatment of various malignancies. In cancer patients given the drug spirogermanium, 40% experienced marked, yet transient neurotoxicity. Two patients suffered from pulmonary toxicity. Results of phases I and II human cancer trials for spirogermanium have not been favorable, with the exception of moderate benefits for three types of malignancies.

It is recommended that patients exposed to long-term (>3 mo) Ge supplementation at levels well above the estimated daily intake be medically supervised and monitored for potential renal-, pulmonaryor neurotoxicity. Further study regarding the mechanism of Geinduced nephrotoxicity in human is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. E. S. Dana,A Textbook of Mineralogy, 4th Ed., Wiley & Sons, New York, 1944.

    Google Scholar 

  2. W. L. Roberts, G. R. J. Rapp, and J. Weber,Encyclopedia of Minerals, Van Nostrand Reinhold, New York, 1974.

    Google Scholar 

  3. R. Schwarz and H. Scholz,Berichte d D Chem. Ges. 74, 1676–1679 (1941).

    Article  Google Scholar 

  4. H. A. Schroeder and J. J. Balassa,J. Chronic. Dis. 20, 211–224 (1967).

    Article  PubMed  CAS  Google Scholar 

  5. E. I. Hamilton and M. J. Minski,Sci. Total. Environ. 1, 341–374 (1972/1973).

    Article  Google Scholar 

  6. W. S. Snyder, M. J. Cook, E. S. Nasset, L. R. Karhausen, G. P. Howells, and I. H. Tipton, inInternational Commission on Radiological Protection, ICRP, New York, 1975.

    Google Scholar 

  7. C. Reilly,Metal Contamination of Food, Applied Science Publishers, London, UK, 1980.

    Google Scholar 

  8. H. Matsumoto, S. Syo, and E. Takahasi,Soil Sci. Plant Nutr. 21, 273–280 (1975).

    CAS  Google Scholar 

  9. M._-K. Park and D._-S. Han,Soul Taehakkyo Yahhak Nonmunjip 4, 100–108 (1979).

    CAS  Google Scholar 

  10. M. Staufer,Erfahrungsheilkunde 29, 646–647 (1980).

    CAS  Google Scholar 

  11. P. D. Whanger inNutrition and Basic and Applied Science, J. N. Hatchcook, ed., Academic, New York, 1982, pp. 163–208.

    Google Scholar 

  12. G. Rosenfeld,Arch. Biochem. Biophys. 48, 84–94 (1954).

    Article  PubMed  CAS  Google Scholar 

  13. G. Rosenfeld and E. J. Wallace,Arch. Indust. Hyg. Occup. Med. 8, 466–479 (1953).

    CAS  Google Scholar 

  14. V. Vouk, inHandbook on the Toxicology of Metals, L. Friberg, G. F. Nordberg, and V. Vouk, eds., Elsevier Science, Amsterdam, 1979, pp. 421–428.

    Google Scholar 

  15. V. Vouk, inHandbook on the Toxicology of Metals, 2nd Ed., L. Friberg, G. F. Nordberg, and V. Vouk, eds., Elsevier Science, Amsterdam, 1986, pp. 255–266.

    Google Scholar 

  16. B. Marczynski,Med. Hypotheses 26, 239–249 (1988).

    Article  PubMed  CAS  Google Scholar 

  17. M. Hatano, K. Ishimura, and K. Fuchigami,Oyo Yakuri 21, 793–796 (1981).

    Google Scholar 

  18. O. Mogilevskaja, inProblems of Industial Hygiene and Occupational Pathology in Work with Rare Metals. Z. I. Israel’son, O. Mogilevsskaja, and S. V. Suvorov, eds., Medicina, Moscow, 1973, pp. 227–239.

    Google Scholar 

  19. H. C. Dudley and E. J. Wallace,Arch. Ind. Hyg. Occup. Med. 6, 263–270 (1952).

    CAS  Google Scholar 

  20. L. M. Rice, J. M. Wheeler, and C. F. Geschickter,J. Heterocyl. Chem. 11, 1041–1047 (1974).

    Article  CAS  Google Scholar 

  21. K. Pinnamaneni, H._-Y. Yap, S. S. Legha, G. R. Blumenschein, and G. P. Bodey,Cancer Treat. Rep. 68, 1197–1198 (1984).

    PubMed  CAS  Google Scholar 

  22. N.J. Volgelzang, D. H. Gesme, and B. J. Kennedy,Am. J. Clin. Oncol. 8, 341–344 (1985).

    Article  Google Scholar 

  23. P. Schulman, R. B. Davis, S. Rafla, M. Green, and E. Henderson,Cancer Treat. Rep. 68, 1305, 1306 (1984).

    PubMed  CAS  Google Scholar 

  24. D. E. Brenner, N. B. Rosenshein, M. Dillon, H. W. Jones, A. Forastiere, S. Tipping, L. S. Burnett, F. A. Greco, and P. H. Wiernik,Cancer Treat. Rep. 69, 457, 458 (1985).

    PubMed  CAS  Google Scholar 

  25. K. Asai,Miracle Cure Organic Germanium, K. Asai Japan Publications, Tokyo, 1980.

    Google Scholar 

  26. M. Tsutsui, D. Kakimoto, D. Axtell, H. Oikawa, and K. Asai,J. Am. Chem. Soc. 98, 8287–8289 (1976).

    Article  CAS  Google Scholar 

  27. N. Kumano, Y. Nakai, T. Kshikawa, S. Koinumaru, S. Suzuki, and K. Konno,Sci. Rep. Res. Inst. Tohoku Univ. 25, 89–95 (1978).

    CAS  Google Scholar 

  28. H. Sato and T. Iwaguchi,Gan To Kagaku Ryoho (Japan J. Cancer Chemotherapy) 6, 79–83 (1979).

    Google Scholar 

  29. H. Aso, Y. Hayashi, F. Suzuki, and N. Ishida,Proc. Jap. Cancer Assn. 38, 112–115 (1979).

    Google Scholar 

  30. T. Suzuki. S. Ishikawa, T. Motoyama, and Oboshi,Acta. Pathol. Jap. 30, 557–564 (1980).

    CAS  Google Scholar 

  31. K. Shimpo and N. Mori,Phamacometrics (Japan) 20, 675–679 (1980).

    CAS  Google Scholar 

  32. K. Miyao, inImmunomodulation by Microbial Products and Related Synthetic Compounds, Y. Yamamura, and S. Kotani, eds., Elsevier, Amsterdam, 1981, pp. 536–539.

    Google Scholar 

  33. N. Kumano, Y. Nakai, T. Ishikawa, S. Koinumaru, S. Suzuki, T. Kikumoto, S. Takizawa, K. Miyao, and K. Konno,Sci. Rep. Res. Inst. Tohoku Univ. 25, 89–95 (1978).

    CAS  Google Scholar 

  34. F. Suzuki,Gan to Kagaku Ryoho (Japan J. Cancer Chemotherapy) 12, 2122–2188 (1985).

    CAS  Google Scholar 

  35. I. Sato, B. Yuan, T. Nishimua, and N. Tanaka,J. Bio. Response Modifiers 4, 159–168 (1985).

    CAS  Google Scholar 

  36. H. Aso, E. Shibuya, F. Susuki, T. Nakamurea, H. Inoue, T. Ebina, and N. Ishida,Gan To Kagaku Ryoho (Japan J. Cancer Chemotherapy) 12, 2345–2351 (1985).

    CAS  Google Scholar 

  37. F. Suzuki, R. R. Brutkiewicz, and R. B. Pollard,Brit. J. Cancer 52, 757–764 (1985).

    PubMed  CAS  Google Scholar 

  38. H. Kobayashi, T. Komuro, and H. Furue,Gan To Kagaku Ryoho (Japan J. Cancer Chemotherapy) 13, 2588–2593 (1986).

    CAS  Google Scholar 

  39. F. Susuki, R. R. Brutkiewicz, and R. B. Pollard,Anticancer Res. 6, 177–182 (1986).

    Google Scholar 

  40. F. Susuki,Gan To Kagaku Ryoho (Japan J. Cancer Chemotherapy) 14, 127–134 (1987).

    Google Scholar 

  41. P. S. Schein, M. Slavik, T. Smythe, D. Hoth, F. Smith, J. S. Macdonald, and P. V. Woolley,Cancer Treat. Rep. 64, 1051–1056 (1980).

    PubMed  CAS  Google Scholar 

  42. S. S. Legha, J. A. Ajani, and G. P. Bodey,J. Clin. Oncol. 1, 331–336 (1983).

    PubMed  CAS  Google Scholar 

  43. C. Trope, W. Mattsson, I. Gynning, J.-E. Johnson, K. Sigurdsson, and B. Orbert,Cancer Treat. Rep. 65, 119, 120 (1981).

    PubMed  CAS  Google Scholar 

  44. G. Falkson and H. C. Falkson,Cancer Treat. Rep. 67, 189, 190 (1983).

    PubMed  CAS  Google Scholar 

  45. J. P. Kuebler, D. C. Tormey, G. R. Harper, Y.-C. Chang, J. D. Khandekar, and G. Falkson,Cancer Treat. Rep. 68, 1515, 1516 (1984).

    PubMed  CAS  Google Scholar 

  46. J. J. Kavanagh, P. B. Saul, L. J. Copeland, D. M. Gershenson, and I. H. Krakoff,Cancer Treat. Rep. 69, 139, 140 (1985).

    PubMed  CAS  Google Scholar 

  47. C. Dixon, F. Hegemeister, S. Legha, and G. Bodey,Cancer Treat. Rep. 68, 907, 908 (1984).

    PubMed  CAS  Google Scholar 

  48. B. T. Hill, S. A. Whatley, A. S. Bellamy, L. Y. Jenkins, and R. D. H. Whelan,Cancer Res. 42, 2852–2856 (1982).

    PubMed  CAS  Google Scholar 

  49. D. R. Budman, P. Schulman, V. Vinciguerra, and T. J. Degnan,Cancer Treat. Rep. 66, 173–175 (1982).

    PubMed  CAS  Google Scholar 

  50. K. Loren,The Report on Germanium, Life Extension Educational Service, Glendale, CA, 1987.

    Google Scholar 

  51. B. Kamen,Germanium, A New Approach to Immunity, Nutrition Encounter, Larkspur, CA, 1987.

    Google Scholar 

  52. Y. Mizushima, Y. Shoji, and K. Kaneko,Int. Arch. Allergy Appl. Immunol. 63, 338, 339 (1980).

    PubMed  Google Scholar 

  53. S. Goodman,Med. Hypotheses 26, 207–215 (1988).

    Article  PubMed  CAS  Google Scholar 

  54. N. J. Vagelzang, D. H. Gesme, and B. J. Kennedy,Am J. Clin. Oncol. 8, 341–344 (1985).

    Article  Google Scholar 

  55. H. A. Schroeder, M. Kanisawa, D. V. Frost, and M. Mitchener,J. Nutr. 96, 37–45 (1968).

    CAS  Google Scholar 

  56. I. Yoneyama,Nippon Jinzo Gakkaishi 24, 1355, 1356 (1982).

    Google Scholar 

  57. N. Nagata, T. Yoneyama, K. Yanagida, K. Ushio, S. Yanagihara, O. Matsubara, and Y. Eishi,J. Toxicol. Sci. 10, 333–341 (1985).

    PubMed  CAS  Google Scholar 

  58. M. Omata, M. Kikuchi, C. Higuchi, S. Sanaka, T. Takuma, N. Sugino, and Y. Mori, inNephrotoxicity of Antibiotics and Immunosuppressants, T. Tanabe, J. B. Hook, and H. Endou, eds., Elsevier, Amsterdam, 1986, pp. 15–20.

    Google Scholar 

  59. K. Okagawa, M. Kosaka, T. Sakikawa, M. Hiasa, H. Sato, K. Morizumi, H. Morita, S. Simomura, and S. Saito,Naika (Japan Arch. Int. Med.) 58, 1211–1214 (1986).

    Google Scholar 

  60. S. Okuda, S. Kiyama, Y. Oh, K. Simamatsu, N. Oochi, K. Kobayashi, F. Nanishi, S. Fujimi, K. Onoyama, and M. Fujishima,Curr. Ther. Res. 41, 265–275 (1987).

    Google Scholar 

  61. T. Matsusaki, M. Fujii, T. Nakano, T. Terai, A. Kurata, M. Imaizumi, and and H. Abe,Clin. Nephrol. 30, 341–345 (1988).

    Google Scholar 

  62. T. Nakano, M. Fuki, T. Terai, T. Matsuzaka, M. Kimura, and T. Toyomasu,J. Clin. Electron Microscopy 20, 850, 851 (1987).

    Google Scholar 

  63. R. Muller and Iszard,Am. J. Med. Sci. 163, 364–372 (1922).

    Article  CAS  Google Scholar 

  64. W. C. Hueper,Am. J. Med. Sci. 181, 820–830 (1931).

    Article  CAS  Google Scholar 

  65. K. Okada, K. Okagawa, K. Kawadami, Y. Kuroda, K. Morizumi, H. Sato, H. Morita, S. Shimomura, and S. Saito,Clin. Nephrol. 31, 219–224 (1989).

    PubMed  CAS  Google Scholar 

  66. J. I. Van der Spoel, B. H. Stricker, M. R. Esseveld, and M. E. I. Schipper,Lancet ii, 117 (1990).

    Google Scholar 

  67. B. H. Stricker,Lancet 337, 864 (1991).

    Article  PubMed  CAS  Google Scholar 

  68. E. Browning,Toxicity of Industrial Metals, 2nd Ed., Butterworths, London, UK, 1969.

    Google Scholar 

  69. K. Asai, Asai Germanium Research Institute, 1984, pp. 1–17.

  70. S. Tomizawa, N. Suguro, and M. Kagoshima,Oyo Yakuri (Japan J. Appl. Pharmacol.) 16, 671–682 (1978).

    CAS  Google Scholar 

  71. K. Miyao, T. Onishi, K. Asai, S. Tomizawa, and F. Suziki, inProceedings of the 11th ICC and the 19th ICAAC, American Society of Microbiology, 1980, pp. 1527–1529.

  72. H. E. Stokinger, inPatty’s Industrial Hygiene and Toxicology, G. D. Clayton and F. E. Clayton, eds., John Wiley, New York, 1981, p. 1493.

    Google Scholar 

  73. A. G. Schauss,Renal Failure 13, 1–4 (1991).

    Article  PubMed  CAS  Google Scholar 

  74. Seizure actions.FDA Consumer 24, 37, 1990.

    Google Scholar 

  75. Seizure actions.FDA Consumer 24, 45, 1990.

    Google Scholar 

  76. R. Krapf,Schweiz Apoth Ztg 129, 10 (1991).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Life Sciences Division, American Institute for Biosocial Research, Inc., PO Box 1174, 98401, Tacoma, WA

    Alexander G. Schauss

Authors
  1. Alexander G. Schauss
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schauss, A.G. Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide. Biol Trace Elem Res 29, 267–280 (1991). https://doi.org/10.1007/BF03032683

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03032683

Index Entries

Search

Navigation